Compugen
CGEN
$2.50
Share price
2.66%
Change (1 day)
136.32%
Change (1 year)
Categories
Compugen (CGEN) - Cash on Hand
Cash on Hand as of March 2024 : $0.10 B
According to Compugen's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Compugen - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $50.68 M | -39.19% |
| 2022-12-31 | $83.34 M | -28.79% |
| 2021-12-31 | $0.11 B | -5.43% |
| 2020-12-31 | $0.12 B | 186.31% |
| 2019-12-31 | $43.22 M | -4.09% |
| 2018-12-31 | $45.07 M | 53.36% |
| 2017-12-31 | $29.38 M | -51.45% |
| 2016-12-31 | $60.53 M | -25.05% |
| 2015-12-31 | $80.77 M | 9.39% |
| 2014-12-31 | $73.83 M | 43.85% |
| 2013-12-31 | $51.33 M | 107.11% |
| 2012-12-31 | $24.78 M | 10.79% |
| 2011-12-31 | $22.37 M | 2.51% |
| 2010-12-31 | $21.82 M | 39.55% |
| 2009-12-31 | $15.63 M | 48.01% |
| 2008-12-31 | $10.56 M | -30.49% |
| 2007-12-31 | $15.2 M | -40.16% |
| 2006-12-31 | $25.4 M | -18.02% |
| 2005-12-31 | $30.98 M | 50.61% |
| 2004-12-31 | $20.57 M | 23.15% |
| 2003-12-31 | $16.7 M | -8.24% |
| 2002-12-31 | $18.2 M | 2.99% |
| 2001-12-31 | $17.67 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | $1.23 B | 1,120.97% | 🇺🇸 USA |
 Genetic Technologies GENE | $2.54 M | -97.49% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $2.99 B | 2,852.27% | 🇮🇱 Israel |
 Eterna Therapeutics ERNA | $5.11 M | -94.95% | 🇺🇸 USA |